Dr. Scott Sherman M.D. to Head Up CannaVision Medical Cannabis and Pain Management Clinic in Sunrise, Florida

LAS VEGAS, NV , Dec. 14, 2017 (GLOBE NEWSWIRE) -- StereoVision Entertainment, Inc. (OTC PINK: SVSN), a publicly traded Nevada Corporation announced today that their majority-owned medical cannabis/industrial hemp subsidiary CannaVision has signed Dr. Scott Sherman M.D. to head up a CannaVision Medical Cannabis and Pain Management Clinic in Sunrise, Florida.

“We’re happy to welcome Dr. Sherman to CannaVision’s medical staff,” said CannaVision’s Chairman and Chief Medical Officer Dr. Jay Ellenby M.D. “Our primary focus is treating vets and cancer patients and I look forward to working with Dr. Sherman. The Miami medical cannabis clinic market has quickly become overcrowded so we’re moving our Coral Gables clinic operations to Sunrise. With Sunrise centered amidst a number of VA medical facilities and cancer treatment centers this area best serves our purpose.”

StereoVision Entertainment Inc. http://stereovision.com Headquartered in Las Vegas, Nevada StereoVision is a publicly traded Nevada corporation (OTC:SVSN) focused on creating, acquiring, and producing multimedia content with its media subsidiaries, the wholly owned 9 time Emmy Award-winning production company REZN8, http://rezn8.com, the majority-owned family entertainment company, Inspirational Vision Media, Inc.  http://ivmi.biz, and the majority-owned medical cannabis clinic and industrial hemp Florida C corporation MediCannaVision Inc., dba CannaVision. http://cannavisionclinics.com

Safe Harbor Statement: Except for historical information certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and those statements are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company cautions that these forward-looking statements are qualified by other factors. The Company undertakes no obligation to publicly update any statements in this release.


Contact Data